Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)

7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)

US Patent 10039724 · Granted Aug 7, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2023
Use of cannabinoids in the treatment of epilepsy2023
Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain 2022
Use of cannabinoids in the treatment of inflammatory skin diseases2022
Use of cannabinoids in the treatment of inflammatory skin diseases2022
Fatty acid amides and uses thereof in the treatment of addiction disorder and ad2022
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in th2021
Use of cannabinoids in the treatment of epilepsy2021
Use of cannabinoids in the treatment of multiple myeloma2021
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity i2020
Cannabinoids for use in the treatment of neurodegenerative diseases or disorders2019